SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,303,621 | -8.8% | 357,694 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $10,205,010 | -19.0% | 357,694 | -30.1% | 0.00% | 0.0% |
| Q2 2022 | $12,602,806 | -76.5% | 511,893 | -46.0% | 0.00% | -75.0% |
| Q1 2022 | $53,525,721 | +50.5% | 948,365 | +65.3% | 0.01% | +71.4% |
| Q4 2021 | $35,563,000 | +12.9% | 573,781 | +15.6% | 0.01% | 0.0% |
| Q3 2021 | $31,488,000 | -27.8% | 496,343 | -6.2% | 0.01% | -22.2% |
| Q2 2021 | $43,592,000 | +35.8% | 528,966 | +21.2% | 0.01% | +28.6% |
| Q1 2021 | $32,101,000 | -6.0% | 436,335 | -7.4% | 0.01% | -12.5% |
| Q4 2020 | $34,156,000 | +187.8% | 470,992 | +89.1% | 0.01% | +166.7% |
| Q3 2020 | $11,870,000 | +26.1% | 249,012 | +11.1% | 0.00% | 0.0% |
| Q2 2020 | $9,416,000 | +74.4% | 224,200 | +12.1% | 0.00% | +50.0% |
| Q1 2020 | $5,400,000 | -29.9% | 200,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $7,698,000 | +77.5% | 200,000 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $4,336,000 | – | 200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |